SKI Market

A+| A| A-|

Indian Indices

Sensex

76,447.60 -880.59
( -1.14%)

Global Indices

Nasdaq

49,619.91 1.93
(0.00%)

Dow Jones

7,417.79 59.68
(0.81%)

Hang Seng

62,681.30 -152.54
(-0.24%)

Nikkei 225

10,228.01 -48.94
(-0.48%)

Forex

USD-INR

94.38 -0.30
(-0.31%)

EUR-INR

110.93 -0.26
(-0.23%)

GBP-INR

128.32 -0.39
(-0.30%)

JPY-INR

0.60 0.00
(-0.28%)

YOU ARE HERE :
HOME
Markets
Equity
Company News Details

EQUITY - MARKET SCREENER

Chandra Bhagat Pharma Ltd

Industry : Pharmaceuticals - Indian - Bulk Drugs & Formln

BSE Code

ISIN Demat

Book Value()

542934

INE07QQ01016

39.720124

NSE Symbol

P/E(TTM)

Mar.Cap( Cr.)

N.A

33.62

23.84

EPS(TTM)

Face Value()

Div & Yield %

0.94

Back

cinevista ltd

Anmol India standalone net profit declines 93.07% in the September 2025 quarter

Nov 14,2025

Net profit of Anmol India declined 93.07% to Rs 0.07 crore in the quarter ended September 2025 as against Rs 1.01 crore during the previous quarter ended September 2024. Sales rose 22.88% to Rs 228.29 crore in the quarter ended September 2025 as against Rs 185.78 crore during the previous quarter ended September 2024.

Particulars	Quarter Ended
	Sep. 2025	Sep. 2024	% Var.
Sales	228.29	185.78	23
OPM %	0.42	1.42	-
PBDT	0.27	1.45	-81
PBT	0.09	1.35	-93
NP	0.07	1.01	-93

76,447.60 -880.59 ( -1.14%)

49,619.91 1.93 (0.00%)

7,417.79 59.68 (0.81%)

62,681.30 -152.54 (-0.24%)

10,228.01 -48.94 (-0.48%)

94.38 -0.30 (-0.31%)

110.93 -0.26 (-0.23%)

128.32 -0.39 (-0.30%)

0.60 0.00 (-0.28%)